The (pre)clinical magnetic resonance platform accommodates cutting-edge magnetic resonance technologies (magnetic resonance imaging, electron paramagnetic resonance and nuclear magnetic resonance) dedicated to studies on biological samples, small animals and humans. These technologies may provide convenient biomarkers for monitoring (patho)physiological parameters and the response to pharmacological treatments.